Literature DB >> 10747338

AT(1) receptor blockade and atherosclerosis : hopeful insights into vascular protection.

D E Vaughan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10747338     DOI： 10.1161/01.cir.101.13.1496

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

1.  Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.

Authors:  Michael T Johnstone; Alexandra S Perez; Imad Nasser; Robert Stewart; Anand Vaidya; Fawaz Al Ammary; Ben Schmidt; Gary Horowitz; Jennifer Dolgoff; James Hamilton; William C Quist
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

2.  The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

Authors:  Mickey M Martin; Jessica A Buckenberger; Jinmai Jiang; Geraldine E Malana; Gerard J Nuovo; Maqsood Chotani; David S Feldman; Thomas D Schmittgen; Terry S Elton
Journal:  J Biol Chem       Date:  2007-06-22       Impact factor: 5.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.